Rasmussen SA - Search Results

1

Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder.

Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, Salloway SP, Okun MS, Goodman WK, Rasmussen SA. Greenberg BD, et al. Among authors: rasmussen sa. Neuropsychopharmacology. 2006 Nov;31(11):2384-93. doi: 10.1038/sj.npp.1301165. Epub 2006 Jul 19. Neuropsychopharmacology. 2006. PMID: 16855529 Clinical Trial.

2

The epidemiology and clinical features of obsessive compulsive disorder.

Rasmussen SA, Eisen JL. Rasmussen SA, et al. Psychiatr Clin North Am. 1992 Dec;15(4):743-58. Psychiatr Clin North Am. 1992. PMID: 1461792 Review.

3

The epidemiology and differential diagnosis of obsessive compulsive disorder.

Rasmussen SA, Eisen JL. Rasmussen SA, et al. J Clin Psychiatry. 1992 Apr;53 Suppl:4-10. J Clin Psychiatry. 1992. PMID: 1564054 Review.

4

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.

Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS. Goodman WK, et al. Among authors: rasmussen sa. Arch Gen Psychiatry. 1990 Jun;47(6):577-85. doi: 10.1001/archpsyc.1990.01810180077011. Arch Gen Psychiatry. 1990. PMID: 2112374 Clinical Trial.

5

Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.

DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S. DeVeaugh-Geiss J, et al. Psychopharmacol Bull. 1990;26(1):54-9. Psychopharmacol Bull. 1990. PMID: 2196627 Clinical Trial.

6

Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.

Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA. Chouinard G, et al. Psychopharmacol Bull. 1990;26(3):279-84. Psychopharmacol Bull. 1990. PMID: 2274626 Clinical Trial.

7

Epidemiology of obsessive compulsive disorder.

Rasmussen SA, Eisen JL. Rasmussen SA, et al. J Clin Psychiatry. 1990 Feb;51 Suppl:10-3; discussion 14. J Clin Psychiatry. 1990. PMID: 2404965 Review.

8

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Goodman WK, et al. Among authors: rasmussen sa. Arch Gen Psychiatry. 1989 Jan;46(1):36-44. doi: 10.1001/archpsyc.1989.01810010038006. Arch Gen Psychiatry. 1989. PMID: 2491940 Clinical Trial.

9

Fluvoxamine as an antiobsessional agent.

Goodman WK, Price LH, Rasmussen SA, Heninger GR, Charney DS. Goodman WK, et al. Among authors: rasmussen sa. Psychopharmacol Bull. 1989;25(1):31-5. Psychopharmacol Bull. 1989. PMID: 2505302 Review.

10

The Yale-Brown Obsessive Compulsive Scale. II. Validity.

Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. Goodman WK, et al. Among authors: rasmussen sa. Arch Gen Psychiatry. 1989 Nov;46(11):1012-6. doi: 10.1001/archpsyc.1989.01810110054008. Arch Gen Psychiatry. 1989. PMID: 2510699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

547 results

Search Page

Filters